Orica Limited ( ($AU:ORI) ) just unveiled an announcement. Orica Limited has announced a change in the director’s interest, with Vikas Bansal acqui......

Oric Pharmaceuticals Inc (ORIC) has disclosed a new risk, in the Employment / Personnel category. Oric Pharmaceuticals Inc.’s strategic pipeline pr......

J.P. Morgan analyst Lee Power maintained a Buy rating on Orica Limited on November 13 and set a price target of A$26.00. The company’s shares close......

Wedbush analyst David Nierengarten maintained a Buy rating on Oric Pharmaceuticals today and set a price target of $20.00. Nierengarten covers the ......

Morgans analyst Belinda Moore maintained a Buy rating on Orica Limited today and set a price target of A$28.00. According to TipRanks, Moore is a 4......

The latest announcement is out from Oric Pharmaceuticals ( ($ORIC) ). Oric Pharmaceuticals announced an update on their ORIC-944 clinical trials, h......

Citi analyst William Park CPA maintained a Buy rating on Orica Limited today and set a price target of A$24.05. Park CPA covers the Industrials sec......

An update from Orica Limited ( ($AU:ORI) ) is now available. Orica Limited has released its corporate governance statement for the financial year e......

The latest update is out from Orica Limited ( ($AU:ORI) ). Orica Limited has released its Corporate Governance Statement for the year ending Septem......

The latest update is out from Orica Limited ( ($AU:ORI) ). Orica Limited reported a strong financial performance for the year ending September 2025......